Leonard M, Brice M, Engel J D, Papayannopoulou T
Division of Hematology, University of Washington, Seattle, WA 98195.
Blood. 1993 Aug 15;82(4):1071-9.
Although the formation of terminally differentiated erythroid cells has been shown to require the presence of a functional GATA-1 gene in vivo, the role of this transcription factor and other members of the GATA family at earlier stages of erythroid differentiation is unclear. In this report, the expression of GATA-1, GATA-2, and GATA-3 has been examined in enriched peripheral blood progenitors before and after culture in a well-characterized liquid culture system. In addition primary leukemic cells as well as several erythroleukemic and nonerythroid cell lines were analyzed for GATA factor expression. The results show that the profile of GATA factor expression in erythroid cells is distinct from that of myeloid or lymphoid lineages. Erythroleukemic cell lines express little or no GATA-3, but high levels of GATA-1 and GATA-2. When they are induced to display the terminal erythroid phenotype, little change in the level of GATA-1 is detected but a significant decline in the levels of GATA-2 is observed commensurate with the degree of maturation achieved by the cells. Enrichment of erythroid progenitors from peripheral blood leads to selection of cells that express both GATA-1 and GATA-2. As the enriched populations are cultured in suspension in the presence of multiple cytokines, the levels of both GATA-1 and GATA-2 initially increase. However, in cultures containing only erythropoietin, which show exclusive erythroid differentiation, the levels of GATA-1 continue to increase, whereas GATA-2 expression declines as erythroid maturation progresses. In contrast, cultures lacking Epo (ie, with interleukin-3 and kit ligand) display limited progression towards both the myeloid and erythroid pathways, and high levels of expression of both GATA-1 and GATA-2 are maintained. Despite the initial upregulation of GATA-1 expression in the latter cultures, terminal erythroid differentiation does not occur in the absence of erythropoietin. These results indicate that GATA-1 upregulation is associated with both the initiation and the maintenance of the erythroid program, but that these two processes appear to be under separate regulatory control. Thus, the dynamic changes in the levels of different GATA factors that occur during primary erythroid differentiation suggest that the levels of these factors may influence the progression to specific hematopoietic pathways.
尽管已证实在体内终末分化的红细胞生成需要功能性GATA-1基因的存在,但该转录因子以及GATA家族其他成员在红细胞分化早期阶段的作用尚不清楚。在本报告中,我们在一个特征明确的液体培养系统中,检测了富集的外周血祖细胞在培养前后GATA-1、GATA-2和GATA-3的表达情况。此外,还分析了原发性白血病细胞以及几种红白血病和非红细胞系中的GATA因子表达。结果表明,红细胞中GATA因子的表达谱与髓系或淋巴系不同。红白血病细胞系几乎不表达或不表达GATA-3,但表达高水平的GATA-1和GATA-2。当它们被诱导呈现终末红细胞表型时,未检测到GATA-1水平有明显变化,但观察到GATA-2水平随着细胞成熟程度的增加而显著下降。从外周血中富集红细胞祖细胞会导致选择同时表达GATA-1和GATA-2的细胞。当富集的细胞群体在多种细胞因子存在的情况下悬浮培养时,GATA-1和GATA-2的水平最初都会升高。然而,在仅含有促红细胞生成素的培养物中,这些培养物显示出特异性的红细胞分化,GATA-1的水平持续升高,而随着红细胞成熟的进展,GATA-2的表达下降。相反,缺乏促红细胞生成素的培养物(即含有白细胞介素-3和干细胞因子配体)向髓系和红细胞系途径的进展有限,并且GATA-1和GATA-2都维持高水平表达。尽管在后者的培养物中GATA-1表达最初上调,但在没有促红细胞生成素的情况下不会发生终末红细胞分化。这些结果表明,GATA-1的上调与红细胞生成程序的启动和维持都有关,但这两个过程似乎受不同的调控控制。因此,在原发性红细胞分化过程中不同GATA因子水平的动态变化表明这些因子的水平可能影响向特定造血途径的进展。